+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pain Management"

Pain Management Devices - A Global Market Overview - Product Thumbnail Image

Pain Management Devices - A Global Market Overview

  • Report
  • November 2024
  • 261 Pages
  • Global
From
U.S. Lidocaine Patches Market Outlook 2034 - Product Thumbnail Image

U.S. Lidocaine Patches Market Outlook 2034

  • Report
  • December 2024
  • 199 Pages
  • United States
From
From
From
From
Global Market for Pain Management Drugs and Devices - Product Thumbnail Image

Global Market for Pain Management Drugs and Devices

  • Report
  • November 2023
  • 171 Pages
  • Global
From
Topical Pain Relief Market - Product Thumbnail Image

Topical Pain Relief Market

  • Report
  • April 2021
  • 122 Pages
  • Global
From
Conventional and Alternative Pain Treatment Markets - Product Thumbnail Image

Conventional and Alternative Pain Treatment Markets

  • Report
  • November 2020
  • 260 Pages
  • Global
From
Loading Indicator

The Pain Management market within the context of Analgesics is a large and diverse field. It includes a variety of products and services designed to reduce or eliminate pain. These products and services range from over-the-counter medications to prescription drugs, physical therapy, and alternative treatments. Analgesics are a type of medication used to reduce or eliminate pain. They can be divided into two main categories: non-opioid analgesics, such as ibuprofen and acetaminophen, and opioid analgesics, such as morphine and oxycodone. Non-opioid analgesics are generally considered to be safer and more effective than opioid analgesics, but they are not as effective at treating severe pain. The Pain Management market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Merck, Novartis, and Eli Lilly. Other companies in the market include Teva Pharmaceuticals, Mylan, and Endo Pharmaceuticals. Show Less Read more